The Future of Cardiac Devices and Electrophysiology

Dear Colleagues,

Technological innovation is rapidly transforming cardiac electrophysiology and electrotherapy. Contemporary cardiac devices are evolving toward miniaturized, leadless, and fully integrated solutions designed to enhance safety, reliability, and patient comfort. Leadless pacemakers and extravascular defibrillators help eliminate complications associated with transvenous leads, while wearable devices enable continuous, non-invasive rhythm monitoring and early arrhythmia detection, extending care far beyond hospital settings. Increasingly, these systems also incorporate intelligent features such as automatic arrhythmia detection and adaptive therapy adjustment, further improving treatment precision.

Artificial intelligence, telemedicine, and digital health platforms now allow real-time data analysis, remote diagnostics, and individualized treatment strategies. These tools enhance clinical decision-making, facilitate early intervention, and promote a more proactive approach to cardiac rhythm management.

This Special Issue, “The Future of Cardiac Devices and Electrophysiology”, invites original research and reviews on emerging technologies in cardiac electrotherapy and electrophysiology.

We particularly encourage submissions on leadless systems, wearable monitoring technologies, AI-based diagnostics, telemedicine solutions, and novel pacing approaches that advance precision and safety in cardiac care.

Prof. Dr. Maciej Sterliński
Dr. Ewa Świerżyńska-Wodarska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.